BioWorld

Jan. 18, 1995

View Archived Issues

CELLPRO BEGINS NEW PHASE III OF CEPRATE SYSTEM FOR MYELOMA

Read More

VESTAR FILES AMENDED DAUNOXOME NDA FOR KAPOSI'S SARCOMA

Read More

ALLELIX COULD NET C$53M FROM DEAL WITH HOECHST- ROUSSEL

Read More

ZYNAXIS ACQUIRES SECRETECH, SEEKS TO DIVEST DIAGNOSTICS

Read More

HYBRIDON SIGNS DEAL WITH PHARMACIA ON PRODUCTION OF ANTISENSE

Read More